Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry

OBJECTIVE: Cholinesterase inhibitors (ChEIs) and memantine are the only approved pharmacological treatments for Alzheimer’s disease (AD). Recent literature suggests reductions in cardiovascular burden and risk of stroke in ChEI users. However, the clinical effectiveness of these drugs in patients wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open Diabetes Res Care
Hlavní autoři: Secnik, Juraj, Schwertner, Emilia, Alvarsson, Michael, Hammar, Niklas, Fastbom, Johan, Winblad, Bengt, Garcia-Ptacek, Sara, Religa, Dorota, Eriksdotter, Maria
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Clinical Care/Education/Nutrition
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039592/
https://ncbi.nlm.nih.gov/pubmed/31958305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000833
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky